Literature DB >> 19457995

Characterization of the behavior of functional viral genomes during the early steps of human immunodeficiency virus type 1 infection.

Vanessa Arfi1, Julia Lienard, Xuan-Nhi Nguyen, Gregory Berger, Dominique Rigal, Jean-Luc Darlix, Andrea Cimarelli.   

Abstract

Infectious viral DNA constitutes only a small fraction of the total viral DNA produced during retroviral infection, and as such its exact behavior is largely unknown. In the present study, we characterized in detail functional viral DNA produced during the early steps of human immunodeficiency virus type 1 infection by analyzing systematically their kinetics of synthesis and integration in different target cells. In addition, we have compared the functional stability of viral nucleoprotein complexes arrested at their pre-reverse transcription state, and we have attempted to measure the kinetics of loss of capsid proteins from viral complexes through the susceptibility of the early phases of infection to cyclosporine, a known inhibitor of the interaction between viral capsid and cyclophilin A. Overall, our data suggest a model in which loss of capsid proteins from viral complexes and reverse transcription occur concomitantly and in which the susceptibility of target cells to infection results from a competition between the ability of the cellular environment to quickly destabilize viral nucleoprotein complexes and the capability of the virus to escape such targeting by engaging the reverse transcription reaction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457995      PMCID: PMC2708621          DOI: 10.1128/JVI.00429-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Uncoating of HIV-1 requires cellular activation.

Authors:  Prasert Auewarakul; Pathawut Wacharapornin; Sirawat Srichatrapimuk; Somchai Chutipongtanate; Pilaipan Puthavathana
Journal:  Virology       Date:  2005-06-20       Impact factor: 3.616

2.  Transduction of nondividing human macrophages with gammaretrovirus-derived vectors.

Authors:  Loraine Jarrosson-Wuilleme; Caroline Goujon; Jeanine Bernaud; Dominique Rigal; Jean-Luc Darlix; Andrea Cimarelli
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells.

Authors:  Theodora Hatziioannou; David Perez-Caballero; Simone Cowan; Paul D Bieniasz
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells.

Authors:  Yan Zhou; Haili Zhang; Janet D Siliciano; Robert F Siliciano
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes.

Authors:  Y D Korin; J A Zack
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Cell cycle arrest in G2/M promotes early steps of infection by human immunodeficiency virus.

Authors:  Bettina Groschel; Frederic Bushman
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Functional analysis of amino acid residues constituting the dNTP binding pocket of HIV-1 reverse transcriptase.

Authors:  D Harris; N Kaushik; P K Pandey; P N Yadav; V N Pandey
Journal:  J Biol Chem       Date:  1998-12-11       Impact factor: 5.157

8.  Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels.

Authors:  L Yin; D Braaten; J Luban
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.

Authors:  Elena Sokolskaja; David M Sayah; Jeremy Luban
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 10.  Early steps of retrovirus replicative cycle.

Authors:  Sébastien Nisole; Ali Saïb
Journal:  Retrovirology       Date:  2004-05-14       Impact factor: 4.602

View more
  37 in total

1.  RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating.

Authors:  Amanda Roa; Fumiaki Hayashi; Yang Yang; Maritza Lienlaf; Jing Zhou; Jiong Shi; Satoru Watanabe; Takanori Kigawa; Shigeyuki Yokoyama; Christopher Aiken; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

Review 2.  Single-molecule stretching studies of RNA chaperones.

Authors:  Hao Wu; Ioulia Rouzina; Mark C Williams
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

3.  Functional analysis of the relationship between Vpx and the restriction factor SAMHD1.

Authors:  Gregory Berger; Jocelyn Turpin; Stéphanie Cordeil; Kevin Tartour; Xuan-Nhi Nguyen; Renaud Mahieux; Andrea Cimarelli
Journal:  J Biol Chem       Date:  2012-10-17       Impact factor: 5.157

4.  Inhibition of reverse transcriptase activity increases stability of the HIV-1 core.

Authors:  Yang Yang; Thomas Fricke; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

5.  Eukaryotic elongation factor 1 complex subunits are critical HIV-1 reverse transcription cofactors.

Authors:  Kylie Warren; Ting Wei; Dongsheng Li; Fangyun Qin; David Warrilow; Min-Hsuan Lin; Haran Sivakumaran; Ann Apolloni; Catherine M Abbott; Alun Jones; Jenny L Anderson; David Harrich
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-24       Impact factor: 11.205

6.  Human cytosolic extracts stabilize the HIV-1 core.

Authors:  Thomas Fricke; Alberto Brandariz-Nuñez; Xiaozhao Wang; Amos B Smith; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2013-07-24       Impact factor: 5.103

7.  Contribution of PDZD8 to stabilization of the human immunodeficiency virus type 1 capsid.

Authors:  Charles Alexander Guth; Joseph Sodroski
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

8.  Evidence for a different susceptibility of primate lentiviruses to type I interferons.

Authors:  Stéphanie Cordeil; Xuan-Nhi Nguyen; Gregory Berger; Stéphanie Durand; Michelle Ainouze; Andrea Cimarelli
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

9.  Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein.

Authors:  Luciano Vozzolo; Belinda Loh; Paul J Gane; Maryame Tribak; Lihong Zhou; Ian Anderson; Elisabeth Nyakatura; Richard G Jenner; David Selwood; Ariberto Fassati
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

10.  Optimal cytoplasmic transport in viral infections.

Authors:  Maria R D'Orsogna; Tom Chou
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.